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Abstract
Objective: Percutaneous tibial nerve stimulation is a recent and minimally invasive treatment for faecal
incontinence (FI). The aim of this study is to evaluate the mid-term results in patients with idiopathic faecal
incontinence (IFI).
Methods: Fifty one patients (42 female and 9 male) were prospectively recruited. Patients were treated twice a
week for 6 weeks as per study protocol. We have assessed the degree of fecal incontinence using the Cleveland
Clinic faecal incontinence (CCF-FI) score at baseline, at 6 weeks, at 6 months and at 1 year. Also the anorectal
manometric data (mean resting pressure (MRP), squeeze pressure (SP) and, rectal sensation) at baseline, at 6
weeks and at 6 months have been evaluated.
Results: The median CCF-FI score was significantly decreased from an initial baseline value from 12 to 7 at 6
weeks, 3 at 6 months and, 3 at 1 year (respectively: 1st interquartile 4.5, 1, 0 vs 10; 3rd interquartile 9, 5, 5 vs 14.5,
p = 0.0001). Anorectal manometry showed an improvement of the internal (resting pressure, MRP) and the external
sphincters (squeeze pressure, SP) at 6 months compared to the baseline and 6 weeks by PTNS, while, RP and SP
at 6 months was greater than at baseline and 6 weeks (p = 0.004 and p = 0.002 respectively).
Conclusions: This study demonstrates that stimulation of the posterior tibial nerve could be an excellent
procedure for the treatment of IFI. The stimulation of the posterior tibial nerve can improve the fecal continence
(CCF-FI score) in the short term and this improvement is maintained after 1 year of follow-up without treatment.
Keywords: Idiopathic faecal incontinence; Posterior tibial nerve
stimulation; Treatment
Introduction
Fecal incontinence (FI) is defined as the involuntary loss of feces or
flatus. It has been underestimated because its existence is often kept
secret by patients [1]. It is a common condition affecting
approximately 2-20% of the adult population in the western world,
with a female: male ratio of 6:1 [2], and mostly affecting women over
the age of 65. FI is caused by the disturbance or disruption of the
various mechanism of the sphincter musculature and its associated
nerve supply, usually following obstetric or anal surgery, trauma,
altered rectal sensation and/or colonic dysmotility. The prevalence of
idiopathic faecal incontinence (IFI) is unknow; a Canadian study has
reported a prevalence of 2%, with no gender preference, and with a
mean age of affected individuals of 47 years [3]. Internal anal sphincter
(IAS) functionally weakness and rectal sensory disturbances contribute
to IFI. Intrapartum anal sphincter injury is the causative factor most
commonly implicated in FI in women [4,5]. However, most women
who sustain anal sphincter injury during vaginal delivery do not go on
to develop FI. Moreover, it is unclear why women who generally
sustain obstetric trauma in the second to third decade develop FI
several decades thereafter [6]. These observations and other objective
assessments of anorectal functions suggest that other risk factors
and/or disturbances of anorectal functions contribute to the
pathophysiology of this disorder. Thus patients with IFI may also have
exaggerated or reduced rectal sensation, and exaggerated anal
sphincter relaxation [7,8]. Its management consists in conservative
treatment such as medical treatment (antidiarrheal medication) and/or
invasive surgery (injection of bulking agents, radiofrequency ablation,
implantation of a neosphincter). Although this kind of treatment may
be helpful, a considerable number of patients require interventional
treatment. Owing to the frequent failure of sphincteroplasty or
artificial sphincter implantation, the technique of neuromodulation
has been developed during the last decade. Sacral neuromodulation
(SNM) has achieved success rates of 60–70% [9,10] but is not free of
complications and also requires the implantation of a non-rechargeable
pulse generator. More recently, posterior tibial nerve stimulation
(PTNS) has been developed as a simple, noninvasive and less expensive
alternative to SNM [11]. It has been shown that PTNS has achieved
adequate success rates, the treatment is not yet generally available and
studies have mostly reported mid-term results [12]. The aim of this
study is to evaluate the mid-term results of posterior tibial nerve
stimulation in patients with idiopathic faecal incontinence (IFI).
Materials and Methods
Before starting ethical approval has been obtained (Pr. 8/11, CE
Palermo). From January, 2012 to September, 2014, 51 patients with
idiopathic FI (42 female and 9 male, mean age 64.54 ± 11.18 years,
range 33-80) were prospectively recruited at the University of
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Palermo’s Digestive Motility Department. The criteria for inclusion
were age between 18 and 80 years, severe FI with a Wexner score of 8
or higher, more than 4 episodes of faecal leakage during a period of 28
days as recorded by the patient in a diary, duration of FI longer than 6
months, failure of conservative treatment (drug, biofeedback or
bulking agents) and integrity anatomical of the external anal sphincter
(EAS) and internal anal sphincter (IAS) by endoanal ultrasound. The
criteria for exclusion were: severe cardiopulmonary disease, lesion of
the tibial posterior nerve, underlying neurological disorders (e.g.,
multiple sclerosis, spinal cord injury, spina bifida, stroke, etc), severe
venous insufficiency of the lower limbs, inflammatory bowel disease,
diabetes, cardiac pacemaker or implantable defibrillator,
immunosuppression, anal fissure, anal fistula or abscess, previous anal
or pelvic surgery and pregnancy. Endoanal ultrasound and pudendal
nerve latency were performed in all patient pre-PTNS to exclude anal
sphincter and nerve injury. Then, all patients have a passive faecal
incontinence without an anal sphincter defect. Before treatment (pre-
PTNS) all patients were given a CCF-FI score (graded 0-20; with 0 =
perfect continence and, 20 = complete incontinence). Their scores were
revised respectively after 6 weeks, 6 months and 1 year from end of the
PTNS cycle (Figure 1). Anorectal manometry was performed to
determine anal resting and squeeze pressure pre-PTNS and also 6
weeks and 6 months post-PTNS. Rectal sensibility was estimated by
the patient’s perception of distension of a latex balloon introduced
through the anus pre-PTNS and 6 weeks and 6 months post-PTNS.
Anal manometry was performed, using, a step-by-step pull-through
technique, with Narco Bio System MMS 200 manometer (International
Biomedical Inc, Austin, Texas) equipped with 8 electrodes connected
to an International Biomedical Model 745-0100 (International
Biomedical Inc, Austin, Texas), pneumo-hydraulic capillary infusion
system with 8 perfusional channels. BEL UDMA20MZ manometric
probes (Bioengineering Laboratories Spa, Italy) were used in various
combinations with an open-end tip provided with 4 helical side-holes
spaced at 1 cm from one another. This was used to determine resting
pressure (MRP, mmHg), pressure maximum voluntary or squeeze
pressure (SP, mmHg) and rectal sensation (threshold volume for first
sensation and desire to defaecate, in ml). The procedure was
standardised. The PTNS was performed using the Urgent PC
Neuromodulation System (Uroplasty, Geleen, Netherlands).
Stimulation was delivered unilaterally using a percutaneous electrode
with the patient in the supine position. A 34-gauge stainless steel
needle was inserted through the skin approximately 3-4 cm above the
medial malleolus between the posterior margin of the tibia and the
soleus muscle tendon. An adhesive earth electrode was placed on the
same leg near the arch of the foot (Stoller’s Technique). Both needle
and electrode were connected to a stimulator with an adjustable pulse
intensity (0–10 mA). Fixed parameters included a pulse width of 200 Is
and a frequency of 20 Hz. The stimulator contained a 9 V battery. The
amplitude was slowly increased until plantar flexion of the large toe or
fanning of the other toes occurred. In most patients, the motor
response was accompanied by a sensory response felt as a radiating
sensation spreading through the sole of the foot. The intensity of
stimulation was set at a level that was well-tolerated.
Elevation of the level of intensity of stimulation was allowed
whenever the sensation faded owing to adaptation. The treatment
protocol consisted of 12 sessions twice per week, with each session
lasting 30 minutes.
Figure 1: Flow-chart.
Statistical Analysis
Continuous variables and CCF-FI scores are summarized as media
and standard deviation, median and 1st and 3rd interquartiles. The
non-parametric Friedman test was used for continuous variables in
multiple comparisons. A p value of less than 0.05 was considered
statistically significant. All statistical analyses were done with XLSTAT
version 7.5.
Results
Table 1 shows the manometric data and Wexner score (median and
standard deviation) obtained during each phase of the study. There was
a significant reduction of symptoms of incontinence (CCF-FI) from
baseline at 6 weeks, 6 months and at 1 year. The median CCF-FI score
was significantly decreased from a baseline of 12 (mean score 12 ±
4.05) to 7 (mean score 6.94 ± 3.35) at 6 weeks, 3 (mean score 3.7 ±
2.84) at 6 months and, 3 (mean score 3 ± 2.69) at 1 year (respectively:
1st interquartile 4.5, 1, 0 vs 10; 3rd interquartile 9, 5, 5 vs 14.5, p =
0.0001) (Figure 2). The anorectal manometry showed an improvement
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functional of the internal sphincter (resting pressure, MRP) and the
external sphincter (squeeze pressure, SP) at 6 months compared to 6
weeks and the baseline by PTNS; MRP at 6 months was greater than at
6 weeks and baseline (median respectively 60 and 50 mmHg vs 46.6; 1st
interquartile 45 and 35 mmHg mmHg vs 37.5; 3rd interquartile 65 and
55 mmHg vs 52.5, p = 0.004). In fact, at the beginning of the PTNS
only 11.76% of patients had a MRP within the normal range and after
6 months of treatment the 35.29% had a MRP within the range (Figure
3). SP at 6 months was greater than 6 weeks and at baseline (median,
respectively: 80 and 85 mmHg vs 75; 1st interquartile 80 and 75 mmHg
mmHg vs 64.5; 3rd interquartile 100 and 113.5 mmHg vs 91.5, p=
0.002) (Figure 4).
There were no statistically significant differences of anorectal
sensation at baseline, 6 weeks and 6 months. However the anorectal
sensation improved at 6 months in 70.5% of patients compared to
58.8% at baseline and 6 weeks (Figure 5).
Figure 2: Wexner score (CCF-FI) during each phase of study.
Figure 3: Resting pressure during each phase of study.
Figure 4: Squeeze pressure during each phase of study.
Figure 5: Anorectic sensation during each phase of study.
 Median Standard Deviation (SD) P value
Age 65.5 ± 11.18  
CCF-FI 12 ± 4.05  
Pre    
CCF-FI 7 ± 3.35  
6 weeks    
CCF-FI 3 ± 2.84  
6 months    
CCF-FI 1
year
3 ± 2.69 0.0001
RP 46.6 ± 20.82  
Pre    
RP 50 ± 24.33  
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6 weeks    
RP 60 ± 18.93 0.004
6 months    
SP 64.5 ± 21.82  
Pre    
SP 85 ± 32.8  
6 weeks    
SP 80 ± 32.35 0.002
6 months    
Table 1: Median and DS of manometric data and Wexner score.
Discussion
This study demonstrates that stimulation of the posterior tibial
nerve could be an excellent procedure for the treatment of IFI. Our
study showed an improvement in the fecal continence (CCF-FI score)
in the short term, after 6 weeks and 6 months from PTNS, and that this
improvement is maintained after 1 year of follow-up without
treatment. Furthermore the manometric data showed that the PTNS
increases the resting pressure and maximum squeeze pressure, to
according the previous study [13]. However, we do not have the one-
year manometric data due to refusal of patients to rerun manometry.
The resting anal pressure was considered as a measure of internal anal
sphincter (IAS) function while the squeeze pressure was considered as
a measure of external anal sphincter function. It has been shown in
various studies that resting anal pressures and squeeze pressures
correlate well with internal anal sphincter and external anal sphincter
function respectively. The normal value IAS pressure is 58-72 mmHg;
the normal value EAS pressure is 100-180 mmHg. The internal anal
sphincter (IAS) provides the greater contribution to resting anal
pressure but the vascular tissue of the anal mucosa and submucosa (the
anal cushions) may also be important by facilitating hermetic closure
of the anal canal . A weak or disrupted IAS or damage to the anal
mucosa or submucosa may lead to passive faecal incontinence where
incontinence episodes occur without patient awareness. Passive faecal
incontinence is the involuntary loss of faeces without the urge to
defecate and is predominantly associated with IAS dysfunction. The
causes of IAS dysfunction can be classified into two main groups: one
type is a morphologically intact but functionally weak IAS (a
phenomenon which may occur with age as part of sclerotic
degeneration) and the second type is a structurally damaged IAS,
which may occur following anal dilatation or ano-rectal surgery,
particularly where the IAS has been deliberately divided for a
sphincterotomy in the treatment of chronic anal fissure. We have
recruited, as mentioned in the materials and methods section, patients
with morphologically intact IAS.
Therefore this method offers excellent results compared with
surgery by reducing the number and severity of incontinence episodes
as expressed by CCF-FI scores, through the improvement of the anal
sphincters function. Tibial nerve stimulation was first used in urology
to treat urge-incontinence and overactive bladder syndrome [14,15].
The exact mechanism of PTNS is unknown but some studies showed,
as the current study, an increase in maximal squeeze pressure
suggesting facilitation of striated muscle function [16]. Increased rectal
sensitivity to balloon distention suggests that peripheral
neuromodulation affects afferent sensory nerves. The tibial nerve
borns from the same sacral nerve roots stimulated by sacral nerve
stimulation (SNM) [17]. Cortical changes during PTNS have been
described, suggesting an important role for the central nervous system.
Positron emission tomography (PET) has shown that SNM increases
blood flow centrally and it seems that activity in some brain areas can
be changed after chronic stimulation [18].
Finazzi-Agro et al. [19] were the first to demonstrate by
somatosensitive evoked potentials that a plastic cortical-level
reorganization could be the mechanism of action after peripheral
stimulation, and they reported close relation-ships between the P100
wave amplitude and possible clinical improvement, so that patients
with a better response to treatment had higher wave amplitudes. One
aspect that has not yet been clarified is the time over which clinical
improvement is maintained in patients who initially respond to PTNS.
The optimal treatment protocol for IFI is not known. Various different
frequencies have been described in literature, varying from daily for 3
months to every other day for 4 weeks [20]. In most series with high
success rates, follow-up is not adequate. There are two studies
reporting a success rate of 100%, but with only 1 month of follow-up
[21-22]. Follow-up is usually < 10 months in most publications. It is
therefore not possible to draw conclusion from these on the duration
of relief of symptoms nor on the need for retreatment. In conclusion,
our study, going over 10 months, showed medium term improvements
in CCF-FI score and anal manometry in patients treated with PTNS.
References
1. De la Portilla F, Laporte M, Maestre MV, Díaz-Pavón JM, Gollonet JL, et
al. (2013) Percutaneous neuromodulation of the posterior tibial nerve for
the treatment of faecal incontinence-mid-term results: is retreatment
required? Colorectal Disease 16: 304-310
2. Perry S, Shaw C, McGrother C, Matthews RJ, Assassa RP, et al. (2002)
Prevalence of faecal incontinence in adults aged 40 years or more living in
the community. Gut 50: 480-484.
3. Ilnyckyj A (2010) Prevalence of idiopathic fecal incontinence in a
community-based sample. Can J Gastroenterol 24: 251-254.
4. Sultan AH, Kamm MA (1997) Faecal incontinence after childbirth. Br J
Obstet Gynaecol 104: 979-982.
5. Sultan AH, Kamm MA, Hudson CN, Thomas JM, Bartram CI (1993)
Anal-sphincter disruption during vaginal delivery. N Engl J Med 329:
1905-1911.
6. Rao SS (2004) Pathophysiology of adult fecal incontinence.
Gastroenterology 126: S14-22.
7. Sun WM, Donnelly TC, Read NW (1992) Utility of a combined test of
anorectal manometry, electromyography, and sensation in determining
the mechanism of 'idiopathic' faecal incontinence. Gut 33: 807-813.
8. Sørensen G, Liao D, Lundby L, Fynne L, Buntzen S, et al. (2014)
Distensibility of the anal canal in patients with idiopathic fecal
incontinence: a study with the Functional Lumen Imaging Probe.
Neurogastroenterol Motil 26: 255-263.
9. Dudding TC, Hollingshead JR, Nicholls RJ, Vaizey CJ (2011) Sacral nerve
stimulation for faecal incontinence: patient selection, service provision
and operative technique. Colorectal Dis 13: 187-195.
10. Maeda Y, Matzel K, Lundby L, Buntzen S, Laurberg S (2011)
Postoperative issues of sacral nerve stimulation for fecal incontinence and
constipation: a systematic literature review and treatment guideline. Dis
Colon Rectum 54: 1443-1460.
11. Klingler HC, Pycha A, Schmidbauer J, Marberger M (2000) Use of
peripheral neuromodulation of the S3 region for treatment of detrusor
overactivity: a urodynamic-based study. Urology 56: 766-771.
Citation: Inviati A, Giovanni SD, Gullo R, Schifano D, Bonventre G, et al. (2016) Percutaneous Tibial Nerve Stimulation for Treatment of
Idiopathic Faecal Incontinence: Mid-term Results from a Single Center. J Gastrointest Dig Syst 6: 401. doi:10.4172/2161-069X.1000401
Page 4 of 5
J Gastrointest Dig Syst
ISSN:2161-069X JGDS, an open access journal Volume 6 • Issue 2 • 1000401
12. Hotouras A, Murphy J, Walsh U, Allison M, Curry A, et al. (2014)
Outcome of percutaneous tibial nerve stimulation (PTNS) for fecal
incontinence: a prospective cohort study. Ann Surg 259: 939-943.
13. López-Delgado A, Arroyo A, Ruiz-Tovar J, Alcaide MJ, Diez M, et al.
(2014) Effect on anal pressure of percutaneous posterior tibial nerve
stimulation for faecal incontinence. Colorectal Dis 16: 533-537.
14. Van der Pal F, Van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans
BL (2006) Percutaneous tibial nerve stimulation in the treatment of
refractory overactive bladder syndrome: is maintenance treatment
necessary? BJU Inter 97: 547-550
15. Wein AJ (2003) Posterior tibial nerve stimulation in the treatment of urge
incontinence. J Urol 169: 2429-2430.
16. Jarrett ME, Varma JS, Duthie GS, Nichols RJ, Kamm MA (2004) Sacral
nerve stimutation for fecal incontinence in the UK. Br J Surg 91: 755-761.
17. Agur A, Dalley A (2009) Atlas of Anatomy. Williams & Wilkins,
Lippincott.
18. Findlay JM, Maxwell-Armstrong C (2011) Posterior tibial nerve
stimulation and faecal incontinence: a review. Int J Colorectal Dis 26:
265-273.
19. Finazzi-Agrò E, Rocchi C, Pachatz C, Petta F, Spera E, et al. (2009)
Percutaneous tibial nerve stimulation produces effects on brain activity:
study on the modifications of the long latency somatosensory evoked
potentials. Neurourol Urodyn 28: 320-324.
20. Shafik A, Ahmed I, El-Sibai O, Mostafa RM (2003) Percutaneous
peripheral neuromodulation in the treatment of fecal incontinence. Eur
Surg Res 35: 103-107.
21. Mentes BB, Yüksel O, Aydin A, Tezcaner T, Leventoglu A, et al. (2007)
Posterior tibial nerve stimulation for faecal incontinence after partial
spinal injury: preliminary report. Tech Coloproctol, 11: 115-119.
22. Findlay JM, Yeung JM, Robinson R, Greaves H, Maxwell-Armstrong C
(2010) Peripheral neuromodulation via posterior tibial nerve stimulation
- a potential treatment for faecal incontinence? Ann R Coll Surg Engl 92:
385-390.
 
Citation: Inviati A, Giovanni SD, Gullo R, Schifano D, Bonventre G, et al. (2016) Percutaneous Tibial Nerve Stimulation for Treatment of
Idiopathic Faecal Incontinence: Mid-term Results from a Single Center. J Gastrointest Dig Syst 6: 401. doi:10.4172/2161-069X.1000401
Page 5 of 5
J Gastrointest Dig Syst
ISSN:2161-069X JGDS, an open access journal Volume 6 • Issue 2 • 1000401
